NCT06338059

Brief Summary

Lipedema is a disease characterized by bilateral abnormal fat deposition in the upper and lower extremities. Pain is a common symptom in lipedema.Vitamin D plays an important role in chronic pain. Vitamin B have analgesic role in some neuropathic pain conditions.This study aimedto evaluate the relationship between vitamin D and vitamin B12 levels and neuropathic pain in lipedema.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 29, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

March 29, 2024

Status Verified

March 1, 2024

Enrollment Period

2 months

First QC Date

March 23, 2024

Last Update Submit

March 23, 2024

Conditions

Keywords

Vitamin D, B12 Deficiency Vitamin,Lipedema,Pain

Outcome Measures

Primary Outcomes (2)

  • Vitamin B12 Level

    Laboratory measurement of patient's vitamin B12 level in unit of pg/mL

    1 day

  • 25 OH Vitamin D Level

    Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl

    1 day

Study Arms (2)

painDETECT questionnaire scores> 13 likely or possible neuropathic pain (group 1)

lipedema patients showing NP symptoms

Other: Vitamin B12 Level

painDETECT questionnaire scores13 unlikely neuropathic pain(group 2)

lipedema patients showing no NP symptoms

Other: Vitamin B12 Level

Interventions

Vitamin B12 Level Laboratory measurement of patient's vitamin B12 level in unit of pg/mL 25 OH Vitamin D Level Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl

Also known as: 25 OH Vitamin D Level
painDETECT questionnaire scores13 unlikely neuropathic pain(group 2)painDETECT questionnaire scores> 13 likely or possible neuropathic pain (group 1)

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

lipedema patients

You may qualify if:

  • The patients diagnosed byan experienced physical medicine and rehabilitation specialist for the diagnosis of lipedema

You may not qualify if:

  • individuals who did not have 25(OH)D and B12 values in the past 6 months,
  • those with a history of gastrectomy or bypass surgery,
  • those consuming a vegetarian diet, those with lymphedema or chronic venous insufficiency, endocrine diseases, rheumatic diseases, malignancy, neurological diseases, and musculoskeletaldiseases that can be related to lower extremity neuropathic or nociceptivepain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulcan Ozturk

Istanbul, 34752, Turkey (Türkiye)

Location

Related Publications (3)

  • Poojari A, Dev K, Rabiee A. Lipedema: Insights into Morphology, Pathophysiology, and Challenges. Biomedicines. 2022 Nov 30;10(12):3081. doi: 10.3390/biomedicines10123081.

  • Kiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a neuroactive substance: review. ScientificWorldJournal. 2006 Jan 26;6:125-39. doi: 10.1100/tsw.2006.25.

  • Gharibpoor F, Ghavidel-Parsa B, Sattari N, Bidari A, Nejatifar F, Montazeri A. Effect of vitamin B12 on the symptom severity and psychological profile of fibromyalgia patients; a prospective pre-post study. BMC Rheumatol. 2022 Sep 1;6(1):51. doi: 10.1186/s41927-022-00282-y.

MeSH Terms

Conditions

Vitamin D DeficiencyVitamin B 12 DeficiencyLipedema

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesVitamin B DeficiencyConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2024

First Posted

March 29, 2024

Study Start

March 1, 2024

Primary Completion

May 1, 2024

Study Completion

June 1, 2024

Last Updated

March 29, 2024

Record last verified: 2024-03

Locations